These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15380632)

  • 21. Bicontinuous cubic liquid crystals as sustained delivery systems for peptides and proteins.
    Rizwan SB; Boyd BJ; Rades T; Hook S
    Expert Opin Drug Deliv; 2010 Oct; 7(10):1133-44. PubMed ID: 20858165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug release from and sterilization of in situ cubic phase forming monoglyceride drug delivery systems.
    Ahmed AR; Dashevsky A; Bodmeier R
    Eur J Pharm Biopharm; 2010 Aug; 75(3):375-80. PubMed ID: 20403431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlling release from the lipidic cubic phase by selective alkylation.
    Clogston J; Craciun G; Hart DJ; Caffrey M
    J Control Release; 2005 Feb; 102(2):441-61. PubMed ID: 15653163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and evaluation of floating risedronate sodium Gelucire 39/01 matrices.
    Chauhan B; Shimpi S; Mahadik K; Paradkar A
    Acta Pharm; 2004 Sep; 54(3):205-14. PubMed ID: 15610617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlling release from the lipidic cubic phase. Amino acids, peptides, proteins and nucleic acids.
    Clogston J; Caffrey M
    J Control Release; 2005 Sep; 107(1):97-111. PubMed ID: 15990192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of organogel as a novel oral controlled release formulation for lipophilic compounds.
    Iwanaga K; Sumizawa T; Miyazaki M; Kakemi M
    Int J Pharm; 2010 Mar; 388(1-2):123-8. PubMed ID: 20045041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of hexacosanol on the characteristics of novel sustained-release allopurinol solid lipospheres (SLS): factorial design application and product evaluation.
    El-Gibaly I; Abdel-Ghaffar SK
    Int J Pharm; 2005 Apr; 294(1-2):33-51. PubMed ID: 15814229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydration of an amphiphilic excipient, Gelucire 44/14.
    Svensson A; Neves C; Cabane B
    Int J Pharm; 2004 Aug; 281(1-2):107-18. PubMed ID: 15288348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of molecular shape on the thermotropic liquid crystal behavior of monolauroylated amino acid glyceride conjugates.
    Morán MC; Pinazo A; Clapés P; Infante MR; Pons R
    J Phys Chem B; 2005 Dec; 109(48):22899-908. PubMed ID: 16853983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solution or suspension - Does it matter for lipid based systems? In vivo studies of chase dosing lipid vehicles with aqueous suspensions of a poorly soluble drug.
    Larsen AT; Holm R; Müllertz A
    Eur J Pharm Biopharm; 2017 Aug; 117():308-314. PubMed ID: 28465239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Swelling of and drug release from monoglyceride-based drug delivery systems.
    Chang CM; Bodmeier R
    J Pharm Sci; 1997 Jun; 86(6):747-52. PubMed ID: 9188059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alginate microspheres of isoniazid for oral sustained drug delivery.
    Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
    Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzymatic erosion of bioartificial membranes to control drug delivery.
    Coluccio ML; Ciardelli G; Bertoni F; Silvestri D; Cristallini C; Giusti P; Barbani N
    Macromol Biosci; 2006 Jun; 6(6):403-11. PubMed ID: 16775815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs.
    Simovic S; Heard P; Hui H; Song Y; Peddie F; Davey AK; Lewis A; Rades T; Prestidge CA
    Mol Pharm; 2009; 6(3):861-72. PubMed ID: 19358600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The thermotropic phase behaviour and phase structure of a homologous series of racemic beta-D-galactosyl dialkylglycerols studied by differential scanning calorimetry and X-ray diffraction.
    Mannock DA; Collins MD; Kreichbaum M; Harper PE; Gruner SM; McElhaney RN
    Chem Phys Lipids; 2007 Jul; 148(1):26-50. PubMed ID: 17524381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of administered dose of lipid-based formulations on the in vitro and in vivo performance of cinnarizine as a model poorly water-soluble drug.
    Lee KW; Porter CJ; Boyd BJ
    J Pharm Sci; 2013 Feb; 102(2):565-78. PubMed ID: 23242691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzyme.
    Shah MH; Paradkar A
    Int J Pharm; 2005 Apr; 294(1-2):161-71. PubMed ID: 15814241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The novel formulation design of O/W microemulsion for improving the gastrointestinal absorption of poorly water soluble compounds.
    Araya H; Tomita M; Hayashi M
    Int J Pharm; 2005 Nov; 305(1-2):61-74. PubMed ID: 16219433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparin.
    Chen MC; Wong HS; Lin KJ; Chen HL; Wey SP; Sonaje K; Lin YH; Chu CY; Sung HW
    Biomaterials; 2009 Dec; 30(34):6629-37. PubMed ID: 19767097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.